Telix Pharmaceuticals reported asset growth of 17.38% for the quarter ended Dec 2025. These growth metrics cover 2 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2024 | Dec2025 |
|---|---|---|
| Growth Ratios | ||
| Assets Growth (1y) | 275.25% | 17.38% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | 479.03% | -69.46% |
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | 94.88% | 99.56% |
| Total Debt Growth (1y) | 6,151.08% | 8.50% |
Pull Telix Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=TLX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "TLX", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=TLX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();